Analysts Have Made A Financial Statement On Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Third-Quarter Report

By Yahoo! Finance | Nov 16, 2024 at 07:58 AM EST

Analysts were overly optimistic on Zevra Therapeutics (NASDAQ: ZVRA) as it underperformed in Q3. Despite revenue growth predictions for 2025, ongoing losses affect valuation. Forecasts indicate the company is expected to outperform the industry in growth.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.